(Corsee) Sanders Corazon - 29 Jun 2021 Form 3 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
Director
Signature
/s/ Karah Parschauer, attorney-in-fact
Issuer symbol
RARE
Transactions as of
29 Jun 2021
Net transactions value
$0
Form type
3
Filing time
30 Jun 2021, 19:56:57 UTC
Previous filing
21 Jun 2021
Next filing
06 Jun 2022

No securities are beneficially owned.

Remarks:

No securities beneficially owned.